ZNF620 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.290590E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.881400E-01
Normal-vs-Stage2
2.958200E-02
Normal-vs-Stage3
2.757800E-03
Normal-vs-Stage4
9.800000E-01
Stage1-vs-Stage2
3.016100E-03
Stage1-vs-Stage3
4.112300E-02
Stage1-vs-Stage4
9.965600E-01
Stage2-vs-Stage3
1.282410E-01
Stage2-vs-Stage4
1.214250E-02
Stage3-vs-Stage4
2.098100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.546010E-01
Normal-vs-AfricanAmerican
2.147500E-02
Normal-vs-Asian
4.867700E-02
Caucasian-vs-AfricanAmerican
8.873400E-01
Caucasian-vs-Asian
7.745000E-01
AfricanAmerican-vs-Asian
9.274200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.464240E-01
Normal-vs-Female
1.195780E-01
Male-vs-Female
8.275400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.927400E-01
Normal-vs-Age(41-60Yrs)
3.397900E-02
Normal-vs-Age(61-80Yrs)
1.821160E-01
Normal-vs-Age(81-100Yrs)
1.145570E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.831500E-04
Age(21-40Yrs)-vs-Age(61-80Yrs)
1.526070E-02
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.662200E-03
Age(41-60Yrs)-vs-Age(61-80Yrs)
6.462800E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.561410E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.242800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.301710E-02
Normal-vs-Daily Drinker
5.904500E-03
Normal-vs-Weekly Drinker
1.086080E-02
Normal-vs-Occasional Drinker
3.637000E-01
Normal-vs-Social Drinker
2.786400E-01
Non Drinker-vs-Daily Drinker
7.509600E-01
Non Drinker-vs-Weekly Drinker
8.148600E-01
Non Drinker-vs-Occasional Drinker
2.487400E-01
Non Drinker-vs-Social Drinker
1.240000E-01
Daily Drinker-vs-Weekly Drinker
9.704400E-01
Daily Drinker-vs-Occasional Drinker
1.873760E-01
Daily Drinker-vs-Social Drinker
9.275800E-02
Weekly Drinker-vs-Occasional Drinker
2.171400E-01
Weekly Drinker-vs-Social Drinker
1.612440E-01
Occasional Drinker-vs-Social Drinker
9.565800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.233750E-01
Normal-vs-Grade 2
1.615780E-02
Normal-vs-Grade 3
2.763900E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.111700E-02
Grade 1-vs-Grade 3
1.518600E-01
Grade 1-vs-Grade 4
1.233750E-01
Grade 2-vs-Grade 3
3.760000E-01
Grade 2-vs-Grade 4
1.615780E-02
Grade 3-vs-Grade 4
2.763900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.298900E-03
Normal-vs-NonDiabetic
1.874170E-01
Diabetic-vs-NonDiabetic
1.475790E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.722610E-03
Normal-vs-NoPancreatitis
1.420400E-01
Pancreatitis-vs-NoPancreatitis
4.659700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.692000E-01
Normal-vs-N1
4.121700E-02
N0-vs-N1
1.769600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.122370E-01
Normal-vs-TP53-NonMutant
6.923000E-01
TP53-Mutant-vs-TP53-NonMutant
1.482310E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
